Unit:
ΠΜΣ Μεταβολικά Νοσήματα των ΟστώνLibrary of the School of Health Sciences
Author:
Marinaki Vasiliki
Supervisors info:
Γεώργιος Λυρίτης, Ομότιμος Καθηγητής, Ιατρική Σχολή, ΕΚΠΑ
Ισμήνη Νίκη Δοντά, Καθηγήτρια, Ιατρική Σχολή, ΕΚΠΑ
Ιωάννης Τριανταφυλλόπολος, Επίκουρος Καθηγητής, Ιατρική Σχολή, ΕΚΠΑ
Original Title:
Προκλήσεις της δημόσιας υγείας στη νοσοκομειακή διαχείριση της σαρκοπενίας
Translated title:
Public health issues in hospital management of sarcopenic patients
Summary:
Sarcopenia is a combination of a progressive and generalized loss of skeletal muscle mass and muscle strength or physical performance, with high risk of adverse outcomes such as physical disability, poor quality of life even death. This definition was given in 2009 by EWGSOP members and is widely used up to date.It mainly affects older people, aged 60-70 years. Sarcopenia is a multifactorial disease and its causes are related to changes in skeletal muscle during aging. The first step towards the management of sarcopenia is the proper and professional diagnosis. According to EWGSOP the diagnosis of sarcopenia depends on the presence of low muscle mass (LMM) plus low muscle strength (LMS) or low physical performance (LPP). It is very difficult to establish reliable rates of prevalence of sarcopenia in the population, mainly because of the type of examined sample, as well as the different definitions used from time to time to determine sarcopenia. Sarcopenia is a multifactorial syndrome, so its treatment should be multifaceted to be effective.It has direct and indirect impact on public health, which are difficult to be measured due to numerous negative outcomes of sarcopenia.
Main subject category:
Health Sciences
Keywords:
Sarcopenia, Public health, Muscle mass, Consequences, Diagnosis
Number of references:
200
